Remdesivir Market Players, Growth | Size, Value Share, Industry Segment and Forecast to 2030
Remdesivir Market Remdesivir is an antiviral drug. FDA approved the remdesivir drug in April 2020 for the clinical trials for COVID 19 treatment. Studies have shown that around 46% of US patients have been recovered from COVID 19 quickly. The growth of the global Remdesivir (COVID 19 ) market can be contributed to the growing need for rescue medication, including remdesivir drugs, due to the outbreak of COVID-19 globally. Furthermore, the rising geriatric population is also expected to fuel market growth during the forecast period. However, the availability of various substitutes for Remdesivir (COVID 19 ) , are expected to restrain the growth of the global Remdesivir (COVID 19 ) market. According to MRFR analysis, Global Remdesivir Market is expected to register a CAGR of 7.90 % during the forecast period of 2020 to 2030 and reach USD 9.88 Billion by 2030. Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Cipla, Pfizer, Merck, Cayman Chemical, Kelun Pharma, Hunan Warrant P